You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • OP0087 Infliximab plus methotrexate inhibits structural damage, reduces sign and symptoms and improves disability in patients with active early rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
OP0087 Infliximab plus methotrexate inhibits structural damage, reduces sign and symptoms and improves disability in patients with active early rheumatoid arthritis

Authors

Citation

Emery P, Maini R, Breedveld F, et al
OP0087 Infliximab plus methotrexate inhibits structural damage, reduces sign and symptoms and improves disability in patients with active early rheumatoid arthritis
Annals of the Rheumatic Diseases 2001;60:A481-A482.

Publication history

  • First published June 1, 2001.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2001, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions